XML 14 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
CURRENT ASSETS:    
Cash and cash equivalents $ 146,484 $ 49,898
Security deposits and leasehold improvements 253 254
Prepaid expenses and other current assets 4,169 4,234
Total current assets 150,906 54,386
Operating lease right-of-use asset 328 447
TOTAL ASSETS 151,234 54,833
CURRENT LIABILITIES:    
Current portion of operating lease liabilities 308 429
Accounts payable 4,019 1,742
Accrued expenses and other current liabilities 14,641 15,286
Warrant liabilities 64,937 53,725
Total current liabilities 83,905 71,182
NONCURRENT LIABILITIES:    
Noncurrent portion of operating lease liabilities 35 38
Clinical holdback - long-term portion   759
Total noncurrent liabilities 35 797
Total liabilities 83,940 71,979
STOCKHOLDERS' EQUITY/(DEFICIT):    
Common stock, $0.0001 par value; 200,000,000 shares authorized as of March 31, 2024 and December 31, 2023; 114,241,803 shares issued and outstanding as of March 31, 2024 and 84,869,832 shares issued and outstanding as of December 31, 2023 11 8
Preferred stock, par value $0.0001; 10,000,000 shares authorized as of March 31, 2024 and December 31, 2023; 0 shares issued and outstanding as of March 31, 2024 and December 31, 2023
Additional paid-in capital 619,807 451,432
Accumulated deficit (552,524) (468,586)
Total stockholders' (deficit)/equity 67,294 (17,146)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY/(DEFICIT) $ 151,234 $ 54,833